Propofol Administration to the Maternal-fetal Unit Improved Fetal EEG and Influenced Cerebral Apoptotic Pathway in Preterm Lambs Suffering from Severe Asphyxia
Overview
Authors
Affiliations
Background: Term and near-term infants are at high risk of developing brain injury and life-long disability if they have suffered from severe perinatal asphyxia. We hypothesized that propofol administration to the maternal-fetal unit can diminish cerebral injury in term and near-term infant fetuses in states of progressive severe asphyxia.
Methods: Forty-four late preterm lambs underwent total umbilical cord occlusion (UCO) or sham treatment in utero. UCO resulted in global asphyxia and cardiac arrest. After emergency cesarean section under either maternal propofol or isoflurane anesthesia, the fetuses were resuscitated and subsequently anesthetized the same way as their mothers.
Results: Asphyctic lambs receiving isoflurane showed a significant increase of total and low-frequency spectral power in bursts indicating seizure activity and more burst-suppression with a marked increase of interburst interval length during UCO. Asphyctic lambs receiving propofol showed less EEG changes. Propofol increased levels of anti-apoptotic B-cell lymphoma-extra large (Bcl-xL) and phosphorylated STAT-3 and reduced the release of cytochrome c from the mitochondria and the protein levels of activated cysteinyl aspartate-specific protease (caspase)-3, -9, and N-methyl-d-aspartate (NMDA) receptor.
Conclusions: Improvement of fetal EEG during and after severe asphyxia could be achieved by propofol treatment of the ovine maternal-fetal unit. The underlying mechanism is probably the reduction of glutamate-induced cytotoxicity by down-regulation of NMDA receptors and an inhibition of the mitochondrial apoptotic pathway.
Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.
Bianco F, Salomone F, Milesi I, Murgia X, Bonelli S, Pasini E Respir Res. 2021; 22(1):71.
PMID: 33637075 PMC: 7908012. DOI: 10.1186/s12931-020-01585-9.
Barkhuizen M, van Dijck F, Jellema R, Gussenhoven R, Engelbertink I, van Mechelen R Pediatr Res. 2018; 83(6):1190-1199.
PMID: 29741516 DOI: 10.1038/pr.2018.42.
Zhong L, Luo F, Zhao W, Feng Y, Wu L, Lin J J Cell Mol Med. 2016; 20(10):1920-31.
PMID: 27297627 PMC: 5020635. DOI: 10.1111/jcmm.12884.
Seehase M, Houthuizen P, Collins J, Zimmermann L, Kramer B Pediatr Res. 2016; 79(5):748-53.
PMID: 26761124 DOI: 10.1038/pr.2016.10.